HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral regimen consisting of UFT/UZEL for elderly patients with colorectal cancer.

AbstractBACKGROUND/AIMS:
A clinical trial has been planned to assess the safety and efficacy of oral administration of UFT and leucovorin (UZEL) in elderly patients with advanced colorectal cancer (CRC).
METHODOLOGY:
Twenty-six patients with advanced CRC who were over 70 years and considered ineligible for combination chemotherapy received oral UFT 300 mg/day and UZEL 75mg/day were administered orally for 28 days followed by a 7-day rest period. Treatment was repeated every 5 weeks until disease progression.
RESULTS:
A total of 106 cycles of UFT/UZEL were administered (median, four cycles; range, one to twelve cycles). UFT/UZEL was well tolerated. The response rate was 11% (3 partial responses, 16 stable diseases, and 7 progressive diseases). The median progression-free survival rate was 3.9 months and the median survival time was 9.8 months. Treatment-related grade 3 and 4 adverse events were not observed.
CONCLUSIONS:
Oral regimen consisting of UFT/ UZEL is effective and well tolerated in elderly patients with advanced CRC who are considered ineligible for combination chemotherapy.
AuthorsSoichi Tsutsumi, Satoru Yamaguchi, Kaori Tsuboi, Takaharu Fukasawa, Sayaka Yamaki, Takayuki Asao, Hiroyuki Kuwano
JournalHepato-gastroenterology (Hepatogastroenterology) 2006 Mar-Apr Vol. 53 Issue 68 Pg. 209-12 ISSN: 0172-6390 [Print] Greece
PMID16608026 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Vitamin B Complex
  • Tegafur
  • Uracil
  • Leucovorin
Topics
  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
  • Colorectal Neoplasms (drug therapy, mortality, pathology)
  • Drug Administration Schedule
  • Female
  • Humans
  • Leucovorin (administration & dosage)
  • Male
  • Survival Rate
  • Tegafur (administration & dosage)
  • Treatment Outcome
  • Uracil (administration & dosage)
  • Vitamin B Complex (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: